Transmembrane and immunoglobulin domain containing 2 is a protein that in humans is encoded by the TMIGD2 gene.[3][4][5][6] TMIGD2 was discovered by Nader Rahimi.[7][8][9]

TMIGD2
Identifiers
AliasesTMIGD2, IGPR-1, IGPR1, CD28H, transmembrane and immunoglobulin domain containing 2
External IDsOMIM: 614715; HomoloGene: 89154; GeneCards: TMIGD2; OMA:TMIGD2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001169126
NM_001308232
NM_144615
NM_001395549

n/a

RefSeq (protein)

NP_001162597
NP_001295161
NP_653216

n/a

Location (UCSC)Chr 19: 4.29 – 4.3 Mbn/a
PubMed search[2]n/a
Wikidata
View/Edit Human

References

edit
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000167664Ensembl, May 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ "Gene: TMIGD2". Ensembl Project.
  4. ^ "TMIG2_HUMAN". UniProt.
  5. ^ "TMIGD2". GeneCards.
  6. ^ "Cell Atlas: TMIGD2". The Human Protein Atlas.
  7. ^ Woolf N, Pearson BE, Bondzie PA, Meyer RD, Lavaei M, Belkina AC, et al. (September 2017). "Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy". Oncogenesis. 6 (9): e378. doi:10.1038/oncsis.2017.77. PMC 5623903. PMID 28920928.
  8. ^ Wang YH, Meyer RD, Bondzie PA, Jiang Y, Rahimi I, Rezazadeh K, et al. (December 2016). "IGPR-1 Is Required for Endothelial Cell-Cell Adhesion and Barrier Function". Journal of Molecular Biology. 428 (24 Pt B): 5019–5033. doi:10.1016/j.jmb.2016.11.003. PMC 5138093. PMID 27838321.
  9. ^ Rahimi N, Rezazadeh K, Mahoney JE, Hartsough E, Meyer RD (May 2012). "Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis". Molecular Biology of the Cell. 23 (9): 1646–56. doi:10.1091/mbc.E11-11-0934. PMC 3338432. PMID 22419821.